NOVONIX Limited (NVX)
Total Valuation
NOVONIX has a market cap or net worth of $788.46 million. The enterprise value is $586.18 million.
Market Cap | 788.46M |
Enterprise Value | 586.18M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
NOVONIX has 121.49 million shares outstanding.
Shares Outstanding | 121.49M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 0.02% |
Float | 55.29M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 2.11 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 54.11, with a Debt / Equity ratio of 0.15.
Current Ratio | 54.11 |
Quick Ratio | 49.80 |
Debt / Equity | 0.15 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -72.43% in the last 52 weeks. The beta is 1.45, so NOVONIX's price volatility has been higher than the market average.
Beta (1Y) | 1.45 |
52-Week Price Change | -72.43% |
50-Day Moving Average | 9.01 |
200-Day Moving Average | 13.96 |
Average Volume (30 Days) | 25,293 |
Short Selling Information
The latest short interest is 14,884, so 0.01% of the outstanding shares have been sold short.
Short Interest | 14,884 |
Short % of Shares Out | 0.01% |
Short % of Float | 0.03% |
Short Ratio (days to cover) | 0.78 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Net Income | n/a |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | -$0.24 |
Balance Sheet
The company has $259.50 million in cash and $57.23 million in debt, giving a net cash position of $202.28 million or $1.67 per share.
Cash & Cash Equivalents | 259.50M |
Total Debt | 57.23M |
Net Cash | 202.28M |
Net Cash Per Share | $1.67 |
Book Value | 374.05M |
Book Value Per Share | 3.08 |
Working Capital | 280.50M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
NOVONIX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Analyst Forecast
The average price target for NOVONIX is $15.30, which is 135.75% higher than the current price. The consensus rating is "Sell".
Price Target | $15.30 |
Price Target Difference | 135.75% |
Analyst Consensus | Sell |
Analyst Count | 7 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |